Belgian venture capital firm Newton BioCapital has led a €15.3m series-B funding round for Acticor Biotech, a clinical-stage biotechnology company involved in the acute phase of thrombotic diseases.
Renewable energy service will also receive future growth funding from the GP
Relationship is set to facilitate access to Pantheon's offering for French institutional investors
Deal follows the acquisition of the company's bank debt by Idea CCR II in December 2017
Newly appointed partner Richard Goldsack previously worked at Grant Thornton and EY